![](/img/cover-not-exists.png)
1509PApplicability of lung immune prognostic index (LIPI) to predict efficacy of first-line pembrolizumab in advanced non-small cell lung cancer (NSCLC)
Mielgo Rubio, X, Gomez Rueda, A, Antoñanzas, M, Falagan, S, Núñez, J A, Sánchez Peña, A M, Gómez-Barreda, I, Martinez Moreno, E, Cerezo Gonzalez, S, Cabezón Gutiérrez, L, Sanchez Torres, J M, JimenezVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz260.031
Date:
October, 2019
File:
PDF, 86 KB
2019